Analysis of the Impact of Cholecystectomy on Gut Microbiome in Adults
Analysis by High-throughput Sequencing: the Impact of Cholecystectomy on Gut Microbiome in Adults
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200127
- Recruiting
- Renji Hospital, School of Medicine, Shanghai Jiao Tong University
-
Sub-Investigator:
- Hui Wang, M.D.
-
Principal Investigator:
- Hong Lu, M.D.,Ph.D.
-
Sub-Investigator:
- Yingjie Ji, M.D.
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Gallbladder polyps diameter mm >10;
- The history of the symptoms of patients with gallbladder stones, there was no history of acute attack in the past month;
- Age <70 years old;
- No serious systemic diseases such as diabetes, hypertension, heart disease, lung disease and so on/American anesthesia Association (ASA) grade I or II;
- BMI<30;
- Families have better care and observation, and away from the hospital within 1 hours; patients and their families understand the process of ambulatory surgery (24 hours) and the pros and cons.
Exclusion Criteria:
- Less than 18 years old;
- With previous gastric surgery ;
- Major systemic diseases ;
- Pregnancy or lactation;
- The use of antibiotics or yogurt within 2 months before the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: Laparoscopic cholecystectomy
A laparoscopic cholecystectomy was performed to remove the gallbladder
|
A special catheter was inserted into the peritoneal cavity, and then about 2-5 liters of carbon dioxide was injected.
After reaching a certain pressure, four small holes of 0.5-1.5cm
were opened in the abdomen to dissect the structure of the triangle of the gallbladder.
The gallbladder duct and gallbladder artery were cut off and closed, and then the entire gallbladder was removed.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of gut microbiota after laparoscopic cholecystectomy
Time Frame: Three months and one year after completion of LC
|
Three months and one year after completion of laparoscopic cholecystectomy therapy, gut microbiota was assessed by 16S rDNA high-throughput sequencing.
|
Three months and one year after completion of LC
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ANTICIPATED)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- rjkls20190208
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.